Blog

ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer – Markets Insider


CNA Finance

ITUS Provides Update on Cancer Detection Technology and New CART Initiative for Ovarian Cancer
Markets Insider
The Wistar Institute's CAR-T technology focuses initially on Ovarian Cancer with potential future applications in Prostate, Pancreatic and other cancers as well. The engineered Tcells will use the Follicle Stimulating Hormone (FSH) to target ovarian
ITUS Corp. (ITUS) Stock: Gaining Big On Clinical UpdateCNA Finance (press release)



all 2 news articles »

2017-09-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.